Introduction {#s1}
============

Anorectal malformations (ARMs, congenital obstruction of the anal opening) are among the most common birth defects requiring surgical treatment (2--5/10,000 live-births) and carry significant chronic morbidity. There is a wide spectrum of defects that differ in terms of malformation severity (ranging from anal stenosis to persistent cloaca) and the presence of different associated congenital anomalies. As shown in the genome-wide copy number variation (CNV) study we published recently [@pone.0069142-Wong1], rare CNVs (either genic or non-genic) private to individual patients are likely to underlie the phenotype. Notably, the CNVs identified differ among patients indicating that ARMs are genetically heterogeneous diseases. Indeed, given the complexity of molecular events that take place during embryonic stages, impairments in any gene members of the pathways controlling the development of the anorectal region could lead to ARMs (or even lethality), thus accounting for the genetic heterogeneity observed among patients. Relevant pathways reported so far in animal studies include WNT, BMP and SHH.

To find out whether the CNVs identified in our study could be assigned to the afore mentioned pathways, we performed an extensive literature search which, coupled with the currently available bioinformatics tools, have allowed us to assign both genic and non-genic CNVs to interrelated pathways known to govern the development of the anorectal region.

Results and Discussion {#s2}
======================

A total of 79 genes distributed among 67 genic-CNV regions (1 recurrent, 66 singletons) and 56 non-genic regions (1 recurrent, 55 singletons) were found uniquely disrupted in 88 out of 170 ARM patients analysed (Table S1 in [File S1](#pone.0069142.s001){ref-type="supplementary-material"}). These CNVs were not reported in the 11,943 healthy individuals from the Database of Genomic Variants (DGV), nor were they found in our 868 control individuals.

Non-genic regions were scrutinized for the presence of regulatory elements controlling the expression of gene members of the relevant pathways. To this end, genomic regions were submitted to RegulomeDB [@pone.0069142-Boyle1], which detects regulatory signatures within the regions, including transcription factor binding sites (TFBS) and expression quantitative trait loci (eQTL) that can be linked to the expression of their target genes. Importantly, RegulomeDB summarizes the data recently released by ENCODE (the Encyclopedia of DNA Elements) [@pone.0069142-Dunham1]. The 79 genes uniquely disrupted by CNVs in patients, together with the TFBS and eQTL target genes, are denoted as "candidate genes" here. Details on the functions and characteristics of these genes were obtained from DAVID bioinformatics resources [@pone.0069142-Huangda1], NCBI Gene (<http://www.ncbi.nlm.nih.gov/gene>) and literature search. For those patients with multiple candidate genes disrupted, the most biologically plausible genes were selected and examined. The relationship among the genes or regulatory regions identified, together with the phenotypic characteristics of the patients are depicted in [Figures 1](#pone-0069142-g001){ref-type="fig"} and [2](#pone-0069142-g002){ref-type="fig"}.

![Candidate genes related to WNT signalling pathway.\
The relevance of the 11 candidate genes (in red: deleted; in blue: duplicated) to WNT signalling pathway is displayed. Sample ID and phenotypes of the patients with gene disruptions are also listed. N: Northern Chinese; S: Southern Chinese.](pone.0069142.g001){#pone-0069142-g001}

![Candidate genes related to the cytoskeleton network.\
The relevance of the 17 candidate genes (in red: deleted; in blue: duplicated) to cytoskeleton network is displayed. Sample ID and phenotypes of the patients with gene disruptions are also listed. N: Northern Chinese; S: Southern Chinese.](pone.0069142.g002){#pone-0069142-g002}

Eleven candidate genes (each altered in a different patient) were assigned/linked to the WNT signalling pathway and one (*ESCIT*) to the WNT related BMP signalling pathway (see [Table 1](#pone-0069142-t001){ref-type="table"} and supplementary material in [File S1](#pone.0069142.s001){ref-type="supplementary-material"} for details). Among those, the three duplicated genes (*DKK4, AMOTL*1 and *PROK1*) known to be antagonists of the WNT/β-catenin signalling [@pone.0069142-Li1]--[@pone.0069142-Li2] are essential for the development of the anorectal region (Table S2 in [File S1](#pone.0069142.s001){ref-type="supplementary-material"}). Importantly, excess of *DKK4* has been associated with the ARMs phenotype in mice [@pone.0069142-Wong1]. Six genes related to β-catenin are affected by CNVs in six ARM patients respectively and are described as follows. Deletions of genes encoding β-catenin-binding proteins (*SOX6, CDH18* and *CTNND2*) and regulatory regions affecting the expression of genes encoding other β-catenin-binding proteins (target genes: *CTNNA1, SOX4)* were detected. In addition, a gene affecting the expression of β-catenin negative regulator (*EAF1)* is duplicated. Genes encoding effectors (*INTU* and *WDPCP*) of the planar cell polarity pathway (PCP; non-canonical WNT signalling) were deleted as well. Apart from PCP effectors, a deletion was observed in *DESI2*, which acts in parallel with the non-canonical WNT signalling pathway regulating cell movement during embryonic development. Planar cell polarity and WNT/β-catenin signalling are inter-related and they interact with other important signalling pathways during embryonic development, including the BMP signalling pathway. *ESCIT*, a cofactor of Smad proteins which mediate BMP signalling, was duplicated in an ARM patient. Defects in the above pathways are known to recapitulate the ARM phenotype in mice [@pone.0069142-Pyati1]--[@pone.0069142-Wen1].

10.1371/journal.pone.0069142.t001

###### List of 11 candidate genes related to the WNT signalling pathway together with one candidate gene (*ECSIT*) related to Bmp signalling pathway.

![](pone.0069142.t001){#pone-0069142-t001-1}

  Gene                        Chr   Start position   End position   Patient ID   Sex   Type of fistula                                                    Associated Anomaly                                                     Type^a^                                         Function
  -------------------------- ----- ---------------- -------------- ------------ ----- ----------------- ----------------------------------------------------------------------------------------------------------------------- --------- --------------------------------------------------------------------------------------
  *PROK1*                      1      111003201       111040235     MG-IA297C     M     Rectourethral                                                           *N.D.*                                                             DUP                Induces expression of *DKK1*, an antagonist of WNT signalling
  *DESI2*                      1      240986292       249219320      MG-IA87C     M     Rectoperineal                                                           *N.D.*                                                             DEL     Acts in parallel with non-canonical WNT signalling pathway to regulate cell movement
  *WDPCP*                      2       63515568        63564683      MG-IA11C     F        *N.D.*                   Down Syndrome, cardiac anomalies, epiblepharon, esotropia, vesicoureteric reflux, Hirschsprung                 DEL                               Effector of Planar Cell Polarity
  *EAF1*                       3       15484269        15565683     MG-IA181C     M     Rectoperineal                                                     Finger deformation                                                       DUP                          Regulates *WNT4* expression with EAF2/U19
  *INTU*                       4      128586241       128620622      MG-IA78C     M     Rectourethral    Down syndrome, cardiac anomalies, ureterovesical junction stricture, epiblepharon, undescended testis, laryngomalacia     DEL                               Effector of Planar Cell Polarity
                                                                    MG-IA349C     F     Rectovaginal                                                            *N.D.*                                                             DEL    
  *CDH18*                      5       19970226        19975567     MG-IA383C     F     Rectoperineal                                                           *N.D.*                                                             DEL                                      Binds to β-catenin
  *SIL1*                       5      138291405       138307306     MG-IA358C     M        *N.D.*                                                           Nephrohydrosis                                                         DEL                             eQTL of *CTNNA,* binds to β-catenin
  192kb upstream of *SOX4*     6       21357289        21402434      MG-IA41C     M     Anocutaneous                                                            *N.D.*                                                             DEL     Overlaps with a TFBS (MEF-2). *SOX4*, the nearest gene, induces β-catenin expression
  *DKK4*                       8       36727529        49890132     MG-IA147C     F     Rectoperineal                                                     Open foramen ovale                                                       DUP                            Antagonist of WNT/β-catenin signalling
  *SOX6*                      11       16253569        16285515     MG-IA128C     F        *N.D.*                                                               *N.D.*                                                             DEL                                      Binds to β-catenin
  *AMOTL1*                    11       91123671        99694305     MG-IA152C     M     Rectoperineal                                                           *N.D.*                                                             DUP                            Antagonist of WNT/β-catenin signalling
  *ECSIT*                     19       11584725        11651810     MG-IA230C     M     Rectoperineal                                                           *N.D.*                                                             DUP                        Coeffector for Smad proteins in Bmp signalling

The functions of these genes were extracted from DAVID bioinformatics resources, NCBI Gene or literature. Positions listed are from UCSC version hg19. *N.D.*: not described in the clinical records. ^a^Type of CNV: DEL, deletion; DUP, duplication.

We also detected the disruption of 17 genes that are functionally related to or located in cytoskeleton ([Table 2](#pone-0069142-t002){ref-type="table"}). Of note, the cytoskeletal network leading to ciliogenesis, intracellular trafficking and cell movements, is regulated by WNT signalling, and especially by PCP [@pone.0069142-Wallingford1], [@pone.0069142-Price1].

10.1371/journal.pone.0069142.t002

###### List of 17 candidate genes related to cytoskeleton.

![](pone.0069142.t002){#pone-0069142-t002-2}

  Gene                          Chr   Start position   End position   Patient ID   Sex   Type of fistula                                                    Associated Anomaly                                                     Type^a^                                              Relevance to cytoskeleton
  ---------------------------- ----- ---------------- -------------- ------------ ----- ----------------- ----------------------------------------------------------------------------------------------------------------------- --------- -----------------------------------------------------------------------------------------------------------------
  *TNNI3K*                       1       74699099        74712181      MG-IA40C     F        *N.D*.                                                               *N.D.*                                                             DUP                                              Cytoskeletal protein binding
  *RCSD1*                        1      167665064       167667620     MG-IA307C     M        *N.D*.                                                               *N.D.*                                                             DEL                                                 Actin filament binding
  *WDPCP*                        2       63515568        63564683      MG-IA11C     F        *N.D.*                   Down Syndrome, cardiac anomalies, epiblepharon, esotropia, vesicoureteric reflux, Hirschsprung                 DEL                          Involved in septin cytoskeleton organization and cilium morphogenesis
  *NLGN1*                        3      173462655       173494302     MG-IA378C     F     Rectoperineal                                                           *N.D.*                                                             DEL                               Involved in cytoskeletal matrix organization at active zone
  *TLR1*                         4       38799710        38820986      MG-IA98C     M        *N.D.*                                                               *N.D.*                                                             DEL                                       eQTL of *KLHL5*, involved in actin binding
  *INTU*                         4      128586241       128620622      MG-IA78C     M     Rectourethral    Down syndrome, cardiac anomalies, ureterovesical junction stricture, epiblepharon, undescended testis, laryngomalacia     DEL                                   Controls ciliogenesis and cytoskeleton organization
                                                                      MG-IA349C     F     Rectovaginal                                                            *N.D.*                                                             DEL    
  *CTNND2*                       5       11335373        11337346     MG-IA384C     F     Rectoperineal                                                           *N.D.*                                                             DEL                                 Regulates cell motility through regulating cytoskeleton
  *SGCD*                         5      155367923       155371739     MG-IA309C     M     Rectourethral                                                           *N.D*.                                                             DEL                                          Involved in cytoskeleton organization
  *LCA5*                         6       80115863        80353483     MG-IA121C     M        *N.D*.                                                               *N.D*.                                                             DUP                                  Locates in microtubule basal body and cilium axoneme
  63kb upstream of *FAM110B*     8       58841890        58844022     MG-IA116C     M     Anocutaneous                                                            *N.D.*                                                             DEL                                   *FAM110B* locates in microtubule organizing center
  38kb upstream of *JAK2*        9       4921639         4947510      MG-IA145C     M     Rectoperineal                                                           *N.D*.                                                             DEL                                    *JAK2* involved in actin filament polymerization
  *FNBP1*                        9      132771351       132803206     MG-IA182C     F     Rectovaginal                                                            *N.D.*                                                             DEL                                        Effector of Rho, locates in cytoskeleton
  *STIM1*                       11       3951337         3970412       MG-IA16C     M     Rectovesical                                         Right indirect inguinal hernia, bifid scrotum                                         DEL                                        Involved in microtubule plus-end binding
  *AMOTL1*                      11       91123671        99694305     MG-IA152C     M     Rectoperineal                                                           *N.D.*                                                             DUP     Induces the remodeling of the actin cytoskeleton through its association with p80-angiomotin-containing complex
  *TBC1D4*                      13       75978839        75998520     MG-IA250C     F        *N.D.*                                                               *N.D.*                                                             DEL                                                  Rab GTPase activator
  *MPRIP*                       17       16764978        17218859     MG-IA226C     M        *N.D.*                                                               *N.D.*                                                             DUP                                                Involved in actin binding
  *TTLL9*                       20       30533883        30552344     MG-IA308C     M        *N.D.*                                                               *N.D.*                                                             DEL                       Locates in microtubule organizing center, microtubule basal body and cilium

The relevance of these genes to the cytoskeleton was extracted from DAVID bioinformatics resources, NCBI Gene or literature. Positions listed are from UCSC version hg19. *N.D.*: not described in the clinical records. ^a^Type of CNV: DEL, deletion; DUP, duplication.

Among the 17 genes, 5 are related to actin filament regulation or binding (*RCSD1, KLHL5, JAK2, AMOTL1*and *MRIP*), 4 are involved in ciliogenesis or located in the cilium (*INTU, WDPCP, LCA5* and *TTLL9*) and 2 are associated to microtubules (*FAM110B* and *STIM1*). Six other genes (*TNNI3K, NLGN1, CTNND2, SGCD, FNBP1* and *TBC1D4)* are involved in regulation and/or organization of the cytoskeleton network. Regulation of the cytoskeleton would probably be important for the downstream process of WNT signalling, though the implication remains unknown.

Close examination of our previous data has allowed us to link 27 candidate genes to interrelated pathways of relevance to the development of the anorectal region. Interestingly, we noted that for WNT signalling, candidate genes with similar function were disrupted by the same type of CNVs in ARM patients: (1) WNT signalling antagonists and β-catenin negative regulators were duplicated; (2) WNT signalling modulators (β-catenin binding proteins and PCP effectors) were all deleted. However, for those genes related to the cytoskeleton network, we did not observe any link between their function and type of lesion by which they were interrupted.

Some features that hint at the pathogenicity, including the mode of inheritance and functional impact of the duplication cannot, however, be established as parental samples are not available and the location of the duplicated copy in the genome is unknown.

Validating all these CNVs in the 27 regions using another technology poses a challenge given limited DNA availability. However, the chance of these CNVs being false positives is low as the CNVs are called by at least two programs. The rarity of the CNVs in these 27 regions, together with the functional regions intersected suggest that indeed these CNVs play a role in ARMs.

Conclusions {#s3}
===========

The data presented here confirm that ARMs are genetically heterogeneous diseases. Also, the fact that genes with similar function within a network are disrupted by the same type of lesion may provide interesting insights into network interacting mechanisms. Ideally, classification of the patients according to type of genetic lesion and pathway affected should lead to improved clinical diagnosis, as well as to the identification of a putative common downstream gene or molecule which could be used as a target for future treatment development.

Materials and Methods {#s4}
=====================

Subjects and ethics statement {#s4a}
-----------------------------

The overall study was approved by the institutional review board of The University of Hong Kong together with the Hospital Authority (IRB: UW 07--321). Blood samples were drawn from all participants after obtaining written informed consent from patients or from parents, guardians or next of kin on behalf of minors.

### ARM patients {#s4a1}

170 Chinese sporadic ARM patients (isolated or with additional associated anomalies) had prospectively been collected throughout Hong Kong and Mainland China. All patients included in this study went through renal ultrasound, lumbosacral radiography and ECHO cardiography. Patients were defined as syndromic if associated anomalies were observed in addition to ARMs.

### Controls {#s4a2}

We included 868 individuals who are phenotypically normal from other studies as controls: 111 controls from a hypertension study [@pone.0069142-Guo1] and 757 individuals from an osteoporosis study [@pone.0069142-Kung1].

Whole-genome CNV scan {#s4b}
---------------------

The whole-genome scan was performed at deCODE Genetics (Reykjavik, Iceland) using Illumina Human 610-Quad BeadChips which assay 599,011 SNPs across the genome and 21,890 intensity-only monomorphic CNV probes. The B allele frequency (BAF) and log R ratio (LRR) were provided by deCODE for CNV calling. Details on CNV prediction and quality controls were described previously [@pone.0069142-Wong1].

Disease gene mapping {#s4c}
--------------------

### Gene-based analysis {#s4c1}

CNV calls in ARM patients were compared against our controls (N = 868) and the 11,943 healthy individuals from the DGV. We selected those genes that were uniquely disrupted by CNVs in ARM patients, but not in controls nor healthy individuals in DGV, for further analysis. Details on the functions and characteristics of these genes were obtained from DAVID (the database for annotation, visualization and integrated discovery) bioinformatics resources [@pone.0069142-Huangda1], NCBI Gene (<http://www.ncbi.nlm.nih.gov/gene>) and literature search.

### Patient-unique non-genic CNV regions {#s4c2}

For those non-genic CNV regions that were uniquely disrupted in ARM patients, we checked if they overlapped with any transcription factor binding sites or expression quantitative trait loci based on the database RegulomeDB [@pone.0069142-Boyle1], which summarized data from ENCODE. Functions of the TFBS nearby genes and eQTL target genes were also obtained from DAVID bioinformatics resources, NCBI Gene and literature search.

### Expression in mouse embryo {#s4c3}

To carefully scrutinize the genes related to ARMs, the list of "candidate genes" has been checked against Eurexpress (Mouse Gene Expression Atlas) for their expression of candidate genes in mouse embryo. Genes have been then categorized into four groups: (1) "with regional signal" if localized expression is observed in the urorectal organ, (2) "without regional signal" if the gene is expressed in the urorectal organ but is not specifically localized in a region, (3) "no signal" if it is not expressed at all in the urorectal organ, and (4) "not available in database" if there is no information on the expression of that gene. Those candidate loci that are not expressed in the mouse urorectal organ (i.e. category 3) have been excluded from the analysis.

Supporting Information {#s5}
======================

###### Supporting text and tables.

**Table S1:** List of the 79 genes and 56 non-genic regions uniquely disrupted in ARMpatients but neither in our 868 controls nor in 11,943 healthy individuals from DGV. **Table S2:** Gene expression during development of the mouse anorectal region (from Eurexpress; Mouse Gene Expression Altas).
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